Literature DB >> 15311113

The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen.

Boris L G Van Wijk1, Olaf H Klungel, Eibert R Heerdink, Anthonius de Boer.   

Abstract

BACKGROUND: Non-compliance is an important factor in lack of control of blood pressure. Uncontrolled blood pressure, as well as patients' complaints about the prescribed medication, may lead to modification of the initially prescribed antihypertensive drug regimen. The objective of this study was to assess the association between non-compliance and change in medication regimen.
METHODS: A nested case-control study within a cohort of new users of antihypertensive drugs between 1 January 1999 and 31 December 2002. We used data from the PHARMO database, a record linkage system containing drug-dispensing records from community pharmacies and linked hospital discharge records of approximately 950,000 subjects. Cases were subjects whose initial drug regimen was modified. Controls did not undergo such a modification. Conditional logistic regression was used to calculate odds ratios (OR) and their 95% confidence intervals (CI), and to adjust for confounders.
RESULTS: In a cohort of 39,714 new users of antihypertensive drugs, we identified 11,937 cases and 11,937 matched controls. The percentage of non-compliant patients (compliance < 80%) among cases and controls was 5.1 and 3.6%, respectively [OR 1.39 (95% CI: 1.22-1.58)]. The association is stronger in females [OR 1.64 (95%CI: 1.37-1.94)] than in males [OR 1.14 (95% CI: 0.94-1.40)] and stronger if the duration of episode of use is longer than 6 months.
CONCLUSION: Non-compliance is significantly associated with the occurrence of change in antihypertensive medication regimen. Pharmacists and physicians can use pharmacy data, although data tend to overestimate actual compliance, to assess and improve compliance with antihypertensive drugs, before modifying treatment regimens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15311113     DOI: 10.1097/00004872-200409000-00029

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  A cross-national study of the persistence of antihypertensive medication use in the elderly.

Authors:  Boris L G van Wijk; William H Shrank; Olaf H Klungel; Sebastian Schneeweiss; M Alan Brookhart; Jerry Avorn
Journal:  J Hypertens       Date:  2008-01       Impact factor: 4.844

2.  Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study.

Authors:  Nariman Mansur; Avraham Weiss; Amnon Hoffman; Tsipora Gruenewald; Yichayaou Beloosesky
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.

Authors:  David J Taber; James N Fleming; Cory E Fominaya; Mulugeta Gebregziabher; Kelly J Hunt; Titte R Srinivas; Prabhakar K Baliga; John W McGillicuddy; Leonard E Egede
Journal:  Am J Nephrol       Date:  2016-12-02       Impact factor: 3.754

4.  Beliefs and practices of Greek doctors in relation to patients' adherence to antihypertensive medication.

Authors:  A Barbouni; M Nalmpanti; D Gennimata; D Theodoridis; K Merakou
Journal:  J Hum Hypertens       Date:  2016-12-29       Impact factor: 3.012

Review 5.  Medication nonadherence: an unrecognized cardiovascular risk factor.

Authors:  Mark A Munger; Benjamin W Van Tassell; Joanne LaFleur
Journal:  MedGenMed       Date:  2007-09-19

6.  Cumulative changes in the use of long-term medications: a measure of prescribing complexity.

Authors:  Khoa D Lam; Yinghui Miao; Michael A Steinman
Journal:  JAMA Intern Med       Date:  2013-09-09       Impact factor: 21.873

7.  Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders.

Authors:  Marcia Vervloet; Liset van Dijk; Jacqueline Santen-Reestman; Bas van Vlijmen; Marcel L Bouvy; Dinny H de Bakker
Journal:  BMC Health Serv Res       Date:  2011-01-10       Impact factor: 2.655

8.  Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis.

Authors:  Xiaoning He; Liming Chen; Ke Wang; Haiya Wu; Jing Wu
Journal:  Patient Prefer Adherence       Date:  2017-02-13       Impact factor: 2.711

9.  Practical application of the ATOM study: Treatment efficacy of antihypertensive drugs in monotherapy or combination (ATOM metaanalysis according to PRISMA statement); tables for the use of antihypertensive drugs in monotherapy or combination.

Authors:  Marco A Paz; Monica Farrerons; Marc Saez; Carme Saurina; Marc Garcia Pinto; Sonia Castro; Javier Sobrino; Gabriel Coll de Tuero
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 10.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.